Mediplantex National Pharmaceutical Joint Stock Company (HNX: MED)
Health Care · Pharmaceuticals · VN
₫—
— today · — 1Y
Mediplantex National Pharmaceutical Joint Stock Company (HNX: MED) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.68M.
trading between 18.40K and 28.60K.
Tweenvest scores Mediplantex National Pharmaceutical Joint Stock Company across four factors: quality 64/100, value 71/100. Its strongest factor is value.
MED price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.68M
- Revenue (TTM)
- $11.07M
- P/E
- 9.51
- EPS
- 1,934.54
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- ₫28,600.00
- 52-week low
- ₫18,400.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.